Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ABEMACICLIB for Neoplasm: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 33 adverse event reports in the FDA FAERS database where ABEMACICLIB was used for Neoplasm.

Most Reported Side Effects for ABEMACICLIB

Side Effect Reports % Deaths Hosp.
Diarrhoea 4,988 30.4% 89 812
Fatigue 1,878 11.5% 23 217
Nausea 1,682 10.3% 27 301
Vomiting 943 5.8% 29 331
Malignant neoplasm progression 890 5.4% 152 216
Decreased appetite 744 4.5% 26 179
Death 696 4.3% 680 44
Asthenia 678 4.1% 18 168
Drug ineffective 668 4.1% 23 47
White blood cell count decreased 566 3.5% 14 130
Anaemia 555 3.4% 48 203
Constipation 513 3.1% 3 83
Abdominal pain upper 509 3.1% 1 74
Neutropenia 509 3.1% 25 106
Dehydration 469 2.9% 15 243

Other Indications for ABEMACICLIB

Breast cancer (4,719) Breast cancer female (3,576) Product used for unknown indication (3,356) Breast cancer metastatic (1,752) Breast cancer recurrent (298) Neoplasm malignant (265) Hormone receptor positive her2 negative breast cancer (220) Invasive ductal breast carcinoma (145) Breast cancer stage iv (117) Bone cancer (90)

Other Drugs Used for Neoplasm

BEVACIZUMAB (502) ATEZOLIZUMAB (404) CYCLOPHOSPHAMIDE (385) CARBOPLATIN (283) PACLITAXEL (267) NIVOLUMAB (219) OXALIPLATIN (185) PEMBROLIZUMAB (173) LENALIDOMIDE (171) DOXORUBICIN (150)

Related Pages

ABEMACICLIB Full Profile All Neoplasm Drugs ABEMACICLIB Demographics ABEMACICLIB Timeline